John B. Moriarty, SVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 10,000 shares at $189.49 ($1.9M) on 2014-10-27, disclosed to the SEC on 2014-10-28.
Scheduled sale ($1.9M) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.49 | 9,927 | $1.9M | 99.3% |
| 2 | $190.00 | 73 | $14K | 0.7% |
| Total | $189.49 avg | 10,000 | $1.9M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |